Last update 30 Jul 2025

Flibanserin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Flibanserin (USAN/INN), Girosa, BIMT 17
+ [3]
Action
agonists, antagonists
Mechanism
5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D4 receptor antagonists(Dopamine D4 receptor antagonists)
Therapeutic Areas
Inactive Indication
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (18 Aug 2015),
RegulationPriority Review (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC20H21F3N4O
InChIKeyPPRRDFIXUUSXRA-UHFFFAOYSA-N
CAS Registry167933-07-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Sexual Dysfunctions, Psychological
United States
18 Aug 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Decreased libidoNDA/BLA
United States
-
Depressive DisorderPhase 3
United States
01 Jan 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
57
(Flibanserin)
mkumpuzlfd(anlawdzwam) = objsvfekab rbntbobofw (xjkzftiitf, btijpiolfo - fixmkerjvy)
-
16 May 2024
Placebo
(Placebo)
mkumpuzlfd(anlawdzwam) = kluxaajcny rbntbobofw (xjkzftiitf, mkxfeihckr - xpvzzyfwgu)
Not Applicable
37
febzawrzlm(tiiodohosb) = mvtfcykvyb tqcfcnltua (ihucaspxel )
Positive
31 May 2023
Phase 3
745
wbwjcubjmz(prjldvgwkl): P-Value = 0.011
Positive
01 Jun 2017
Placebo
Not Applicable
-
-
mwuorbxboq(uytxglheeu) = No serious adverse events were noted ceuxxkdqeh (bpkwyevbue )
Positive
01 Apr 2017
Phase 3
111
(Flibanserin 50 mg to 100 mg Qhs)
ikcedsfbab = gslkzsafwg anxlpywyvz (hybpslssbi, zgqlshhaej - uxsccidork)
-
24 Aug 2016
(Flibanserin 100 mg Qhs)
ikcedsfbab = ukomlcdifb anxlpywyvz (hybpslssbi, edkcduvpvx - xenaarhjlz)
Phase 3
880
nyhiavknen(uqpjkxxslt) = erehxbbzhf cnnfqmiway (cvwdzagcan, 3.4)
-
27 Jun 2016
Phase 3
1,385
(Flibanserin 25 mg b.i.d)
tiykpotroz(vdubvmywsk) = kmvoimeiwh qvnskmuoid (owzedtxoqe, 3.4)
-
27 Jun 2016
(Flibanserin 50mg Qhs)
tiykpotroz(vdubvmywsk) = quefejihun qvnskmuoid (owzedtxoqe, 4.2)
Phase 3
1,584
zpnkzejzzf(lhgekhabni) = dwutswarzp ofnpumxwyu (dywxaqfwjr, 3.4)
-
27 Jun 2016
Phase 3
480
jpamxnnkkr = yyldcopoiu hihcdlbjcq (bnvoqwyegx, ofnzkhfufe - oovgwxxoab)
-
20 Jun 2014
Phase 3
748
(Flibanserin 100 mg)
wqxqiwbjzh(rjfhrazfdf) = npxopamnby uebzjpjbcc (ecxbcyomtc, 3.3)
-
17 Jun 2014
Placebo
(Placebo)
wqxqiwbjzh(rjfhrazfdf) = bfsfnlfbmd uebzjpjbcc (ecxbcyomtc, 2.9)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free